1. Home
  2. ZVSA vs LYT Comparison

ZVSA vs LYT Comparison

Compare ZVSA & LYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVSA
  • LYT
  • Stock Information
  • Founded
  • ZVSA 2014
  • LYT 2020
  • Country
  • ZVSA United States
  • LYT India
  • Employees
  • ZVSA N/A
  • LYT N/A
  • Industry
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • LYT EDP Services
  • Sector
  • ZVSA Health Care
  • LYT Technology
  • Exchange
  • ZVSA Nasdaq
  • LYT Nasdaq
  • Market Cap
  • ZVSA 1.5M
  • LYT 1.8M
  • IPO Year
  • ZVSA N/A
  • LYT 2022
  • Fundamental
  • Price
  • ZVSA $1.42
  • LYT $0.72
  • Analyst Decision
  • ZVSA Strong Buy
  • LYT
  • Analyst Count
  • ZVSA 1
  • LYT 0
  • Target Price
  • ZVSA $240.00
  • LYT N/A
  • AVG Volume (30 Days)
  • ZVSA 2.2M
  • LYT 4.4M
  • Earning Date
  • ZVSA 11-14-2024
  • LYT 08-15-2024
  • Dividend Yield
  • ZVSA N/A
  • LYT N/A
  • EPS Growth
  • ZVSA N/A
  • LYT N/A
  • EPS
  • ZVSA N/A
  • LYT 0.30
  • Revenue
  • ZVSA N/A
  • LYT $21,363,775.00
  • Revenue This Year
  • ZVSA N/A
  • LYT N/A
  • Revenue Next Year
  • ZVSA N/A
  • LYT N/A
  • P/E Ratio
  • ZVSA N/A
  • LYT $2.42
  • Revenue Growth
  • ZVSA N/A
  • LYT 12.39
  • 52 Week Low
  • ZVSA $0.98
  • LYT $0.54
  • 52 Week High
  • ZVSA $25.00
  • LYT $18.62
  • Technical
  • Relative Strength Index (RSI)
  • ZVSA 57.25
  • LYT 30.59
  • Support Level
  • ZVSA $1.31
  • LYT $0.54
  • Resistance Level
  • ZVSA $1.95
  • LYT $0.76
  • Average True Range (ATR)
  • ZVSA 0.19
  • LYT 0.08
  • MACD
  • ZVSA 0.04
  • LYT 0.01
  • Stochastic Oscillator
  • ZVSA 44.21
  • LYT 40.91

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

About LYT Lytus Technologies Holdings PTV. Ltd.

Lytus Technologies Holdings Pvt Ltd is a platform services company providing content streaming/telecasting services to users located all across India. Its scope of business also covers telemedicine services with local assistance through local Health Centers. Through its platform, the customers are well connected via customer premises equipment (CPE) devices/set-top boxes (STBs) and have access to multi-dimensional services including telemedicine service.

Share on Social Networks: